Related Experiment Video
Updated: Jun 5, 2025
Genome-wide Protein-protein Interaction Screening by Protein-fragment Complementation Assay PCA in Living Cells
Published on: March 3, 2015
CancerHubs: a systematic data mining and elaboration approach for identifying novel cancer-related protein
Ivan Ferrari1,2, Federica De Grossi1,2, Giancarlo Lai1,2
1INGM, Istituto Nazionale Genetica Molecolare Romeo ed Enrica Invernizzi, Milan, Italy.
Abstract:
Conventional approaches to predict protein involvement in cancer often rely on defining either aberrant mutations at the single-gene level or correlating/anti-correlating transcript levels with patient survival. These approaches are typically conducted independently and focus on one protein at a time, overlooking nucleotide substitutions outside of coding regions or mutational co-occurrences in genes within the same interaction network. Here, we present CancerHubs, a method that integrates unbiased mutational data, clinical outcome predictions and interactomics to define novel cancer-related protein hubs. Through this approach, we identified TGOLN2 as a putative novel broad cancer tumour suppressor and EFTUD2 as a putative novel multiple myeloma oncogene.
Insights
CancerHubs integrates mutation data and interactomics to find novel cancer drivers. This method identified TGOLN2 as a tumor suppressor and EFTUD2 as an oncogene in multiple myeloma.
Area of Science:
- Genomics
- Bioinformatics
- Cancer Biology
Background:
- Traditional cancer research often analyzes single genes or transcript levels independently, missing complex interactions and non-coding mutations.
- Existing methods overlook the significance of mutations outside coding regions and co-occurring mutations within gene networks.
Purpose of the Study:
- To develop a novel computational method, CancerHubs, for identifying cancer-related protein hubs by integrating diverse biological data.
- To uncover new protein players in cancer development and progression using a systems biology approach.
Main Methods:
- CancerHubs integrates unbiased whole-genome mutation data, clinical outcome predictions, and protein-protein interaction networks (interactomics).
- The method analyzes large-scale datasets to identify proteins acting as central hubs in cancer-related networks.
Main Results:
- Identification of TGOLN2 as a potential novel tumor suppressor gene involved across various cancer types.
- Identification of EFTUD2 as a potential novel oncogene specifically implicated in multiple myeloma.
Conclusions:
- CancerHubs provides a powerful, integrated approach to discover novel cancer-associated proteins and their roles.
- The findings highlight TGOLN2 and EFTUD2 as promising targets for future cancer diagnostics and therapeutics.
Related Concept Videos
02:04Protein-protein Interfaces
02:26Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...